MSDC 0160
CAS: 146062-49-9
Ref. TM-T2607
| 1mg | 35.00 € | ||
| 2mg | 50.00 € | ||
| 5mg | 77.00 € | ||
| 10mg | 100.00 € | ||
| 25mg | 154.00 € | ||
| 50mg | 197.00 € | ||
| 100mg | 350.00 € | ||
| 200mg | 304.00 € | ||
| 1mL*10mM (DMSO) | 83.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Product Information
Name:
MSDC 0160
Synonyms:
- MSDC0160
- Mitoglitazone
- CAY10415
- 5-[[4-[2-(5-Ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-2,4-thiazolidinedione
- 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)-2-oxoethoxy]phenyl]methyl]-
- CAY 10415
Description:
MSDC 0160 (CAY10415) is a prototype mTOT-modulating insulin sensitizer being used in trials studying the treatment of Type 2 Diabetes and Alzheimer's Disease.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
370.42
Formula:
C19H18N2O4S
Purity:
99.45% - 99.53%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T2607 MSDC 0160
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
